Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura

gan Bennett, Carolyn M., Rogers, Zora R., Kinnamon, Daniel D., Bussel, James B., Mahoney, Donald H., Abshire, Thomas C., Sawaf, Hadi, Moore, Theodore B., Loh, Mignon L., Glader, Bertil E., McCarthy, Maggie C., Mueller, Brigitta U., Olson, Thomas A., Lorenzana, Adonis N., Mentzer, William C., Buchanan, George R., Feldman, Henry A., Neufeld, Ellis J.
Cyhoeddwyd 2006

One Year Follow-Up of Children and Adolescents With Chronic Immune Thrombocytopenic Purpura (ITP) Treated With Rituximab

gan Mueller, Brigitta U., Bennett, Carolyn M., Feldman, Henry A., Bussel, James B., Abshire, Thomas C., Moore, Theodore B., Sawaf, Hadi, Loh, Mignon L., Rogers, Zora R., Glader, Bertil E., McCarthy, Maggie C., Mahoney, Donald H., Olson, Thomas A., Feig, Stephen A., Lorenzana, Adonis N., Mentzer, William C., Buchanan, George R., Neufeld, Ellis J.
Cyhoeddwyd yn Pediatr Blood Cancer (2009)